Not for release or distribution, directly or indirectly, within, into or in the United States or to or for the account or benefit of persons in the United States, Australia, Canada, Japan or any other jurisdiction where such offer or sale would violate the relevant securities laws of such jurisdiction.
For Immediate Release
29 September 2023
Adalan Ventures Plc
("Adalan" or the "Company")
Unaudited interim results
Adalan Ventures plc (the 'Company' or 'Adalan'), announces its unaudited annual results for the 6 months ended 30 June 2023
Adalan Ventures plc
Interim Condensed Consolidated Statement of profit or loss and Other Comprehensive Income for the six months ended 30 June
| Notes | Six months ended 30 June 2023 Unaudited GBP'000 | Six months ended 30 June 2022 Unaudited GBP'000 |
| | | |
Other income | | - | 55 |
Charge for share options granted | | - | (3) |
Administrative expenses | | (10) | (180) |
exchange gains | | | 3 |
Loss before income tax |
| (10) | (125) |
Income tax expense | | - | - |
Net loss |
| (10) | (125) |
|
|
|
|
Net other comprehensive income that may be reclassified to profit or loss |
|
|
|
Foreign exchange differences arising on translation into presentation currency |
| - | - |
| |||
Total comprehensive loss | | (10) | (125) |
Adalan Ventures plc
Interim Condensed Consolidated Statement of financial position as at
| Notes | 30 June 2023 Unaudited GBP'000 | 31 December 2022 Audited GBP'000 |
| | | |
|
| | |
Assets: |
| | |
Cash and cash equivalents |
| 29 | 35 |
Total Assets |
| 29 | 35 |
| | | |
| | | |
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
Other liabilities |
| (377) | (374) |
Total liabilities |
| (377) | (374) |
Net Assets |
| (348) | (339) |
Equity |
|
|
|
Capital and reserves: |
|
|
|
Charter capital | 8 | 4,620 | 4,620 |
Shares to be issued Reserve | | 800 | 800 |
Additional capital | 8 | 6,756 | 6,756 |
Share options Reserve |
| 248 | 248 |
Accumulated deficit | | (12,772) | (12,761) |
Total equity |
| (348) | (339) |
Total liabilities and equity |
| 29 | 35 |
Interim Condensed Statement of changes in shareholders' equity (Unaudited) for the six months ended 30 June 2023 (unaudited)
| Charter capital GBP'000 |
Shares to be issued Reserve | Additional capital GBP'000 |
Share options Reserve | Accumulated Deficit GBP'000 | Total GBP'000 |
Balance as at 1 January 2023 | 4,620 |
800 |
6,756 |
248 |
(12,761) |
(339) |
Issue of ordinary shares | - | - | - | - | - | - |
Comprehensive loss for the period | - |
- | - |
- | (10) | (10) |
Share-based payments | - |
- | - |
- | - | - |
Balance as at 30 June 2023 |
4,620 |
800
|
6,756 |
248 |
(12,772) |
(348) |
Interim Condensed Consolidated Statement of Cash Flows
For the six months ended 30 June
| Six months ended 30 June 2023 Unaudited GBP'000 | Six months ended 30 June 2022 Unaudited GBP'000 |
| | |
Cash flows from operating activities |
| |
Loss for the period | (10) | (125) |
Non cash items - Share based payments | - | 3 |
Cash from operations | (10) | (122) |
| | |
Net (increase)/decrease in operating assets |
| |
Change in receivables | | (30) |
Change in payables | 4 | 92 |
Net change in working capital | 4 | 63 |
Net cash flows from operating activities | (6) | (59) |
Net change in cash and cash equivalents | (6) | (59) |
Cash and cash equivalents at the beginning of the year | 35 | 212 |
Cash and cash equivalents at the end of the period | 29 | 152 |
2. Basis of preparation
The condensed consolidated interim financial statements have been prepared using accounting policies consistent with International Financial Reporting Standards and in accordance with International Accounting Standard 34 Interim Financial Reporting. The condensed interim financial statements should be read in conjunction with the annual financial statements for the year ended 31 December 2022, which have been prepared in accordance with International Financial Reporting Standards (IFRS).
The condensed consolidated interim financial statements set out above do not constitute statutory accounts within the meaning of the Companies Act 2006. They have been prepared on a going concern basis in accordance with the recognition and measurement criteria of International Financial Reporting Standards (IFRS). Statutory financial statements for the year ended 31 December 2022 were approved by the Board of Directors on 31 August 2023 and delivered to the Registrar of Companies. The report of the auditors on those financial statements was unqualified.
The condensed consolidated interim financial statements of the Company have not been audited or reviewed by the Company's auditor, Shipley's LLP.
Going concern
The Financial Statements have been prepared on a going concern basis. The Directors consider that the Company requires additional funding in order to deliver on its plan to find and acquire an operating business and undertake a reverse take over. The Directors are of the view that its current cash reserves along with any funding that it will seek to raise would provide sufficient funds to undertake its operating activities for the foreseeable future. Should the company be unsuccessful in raising additional capital then there is a significant risk that it has the ability to continue as a going concern. The company has currently reduced its cash expenditure to a minimum.
Please refer to the going concern note in the annual report for the year ended 31 December 2022 for further information.
Further information can be found at the corporate website: https://adalanventures.com/
Enquiries:
Adalan Ventures Plc | |
Siro Cicconi |
Tel: +44 (0) 73 9377 9849 |
| |
| |
Optiva Securities Limited | |
Vishal Balasingham | Tel: +44 (0) 20 3137 1902 |
| |
| |
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.